Skip to main content
. 2017 Jun 16;83(13):e00337-17. doi: 10.1128/AEM.00337-17

FIG 8.

FIG 8

Impact of mitomycin C on ICE_SsaF1-4_fda excision. Fragments corresponding to the recombination sites attB and attI of nontreated (MMC−) or treated (MMC+) cells were amplified by PCR using template DNA quantities ranging from 0.1 μg to 1 pg. The amplification of the fda gene was used as a control.